Abstract
The human dopamine transporter (DAT1) gene contains a variable number of tandem repeats (VNTR) in its 3′-untranslated region (UTR). The linkage and association between the VNTR polymorphism of DAT1 and various neuropsychiatric disorders have been reported. We have determined the genomic structure of DAT1 genes containing 7-, 9-, 10-, and 11-repeat alleles and examined the effect of VNTR polymorphism in the 3′-UTR region of DAT1 on gene expression using the luciferase reporter system in COS-7 cells. Luciferase expression was significantly higher when the 3′-UTR of the DAT1 gene contained the 10-repeat allele than when it contained the 7- or 9-repeat alleles. This suggests that VNTR polymorphism affects the expression of the dopamine transporter.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Iversen LL . Role of transmitter uptake mechanisms in synaptic neurotransmission Br J Pharmacol 1971 41: 571–591
Vandenbergh DJ, Persico AM . A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic Taq I RFLPs Mol Brain Res 1992 15: 161–166
Amara SG, Kuhar MJ . Neurotransmitter transporters: recent progress Annu Rev Neurosci 1993 16: 73–93
Giros B, Caron MG . Molecular characterization of the dopamine transporter Trends Pharmacol Sci 1993 14: 43–49
Giros B, el Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T et al . Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter Mol Pharmacol 1992 42: 383–390
Giros B, Jaber M, Jones SR, Wightman RM, Caron MG . Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature 1996 379: 606–612
Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW et al . Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR Genomics 1992 14: 1104–1106
Sano A, Kondoh K, Kakimoto Y, Kondo I . A 40-nucleotide repeat polymorphism in the human dopamine transporter gene Hum Genet 1993 91: 405–406
Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE et al . Association of attention-deficit disorder and the dopamine transporter gene Am J Hum Genet 1995 56: 993–998
Le Couteur DG, Leighton PW, McCann SJ, Pond SM . Association of a polymorphism in the dopamine-transporter gene with Parkinson’s disease Mov Disord 1997 12: 760–763
Mercier G, Turpin JC, Lucotte G . Variable number tandem repeat dopamine transporter gene polymorphism and Parkinson’s disease: no association found J Neurol 1999 246: 45–47
Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A et al . Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium Biol Psychiatry 1997 41: 299–304
Franke P, Schwab SG, Knapp M, Gansicke M, Delmo C, Zill P et al . DAT1 gene polymorphism in alcoholism: a family-based association study Biol Psychiatry 1999 45: 652–654
Muramatsu T, Higuchi S . Dopamine transporter gene polymorphism and alcoholism Biochem Biophys Res Commun 1995 211: 28–32
Blum K, Braverman ER, Wu S, Cull JG, Chen TJ, Gill J et al . Association of polymorphisms of dopamine D2 receptor (DRD2), and dopamine transporter (DAT1) genes with schizoid/avoidant behaviors (SAB) Mol Psychiatry 1997 2: 239–246
Inada T, Sugita T, Dobashi I, Inagaki A, Kitao Y, Matsuda G et al . Dopamine transporter gene polymorphism and psychiatric symptoms seen in schizophrenic patients at their first episode Am J Med Genet 1996 67: 406–408
Maier W, Minges J, Eckstein N, Brodski C, Albus M, Lerer B et al . Genetic relationship between dopamine transporter gene and schizophrenia: linkage and association Schizophr Res 1996 20: 175–180
Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al . Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region Science 1996 274: 1527–1531
Joensson EG, Nothen MM, Gustavsson JP, Neidt H, Bunzel R, Propping P et al . Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CFS of healthy volunteers Psychiatry Res 1998 79: 1–9
Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG et al . Genotype influences in vivo dopamine transporter availability in human striatum Neuropsychopharmacology 2000 22: 133–139
Jacobson LK, Staley JK, Zoghbi SS, Seibyl JP, Kosten TR, Innis RB et al . Prediction of dopamine transporter binding availability by genotype: a preliminary report Am J Psychiatry 2000 157: 1700–1703
Laine TPJ, Ahonen A, Torniainen P, Heikkila J, Pyhtinen J, Rasanen P et al . Dopamine transporters increase in human brain after alchol withdrawal Mol Psychiatry 1999 4: 189–191
Ueno S, Nakamura M, Mikami M, Kondoh K, Ishiguro H, Arinami T et al . Identification of a novel polymorphism of the human dopamine transporter (DAT1) gene and the significant association with alcoholism Mol Psychiatry 1999 4: 552–557
Koike H, Tomioka S, Sorimachi H, Saido SC, Maruyama K, Okuyama A et al . Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein Biochem J 1999 343: 371–375
Chu G, Hayakawa H, Berg P . Electroporation for the efficient transfection of mammalian cells with DNA Nucl Acid Res 1987 15: 1311–1326
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fuke, S., Suo, S., Takahashi, N. et al. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 1, 152–156 (2001). https://doi.org/10.1038/sj.tpj.6500026
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.tpj.6500026
Keywords
This article is cited by
-
The dopamine transporter gene SLC6A3: multidisease risks
Molecular Psychiatry (2022)
-
Epigenetic moderators of naltrexone efficacy in reducing heavy drinking in Alcohol Use Disorder: a randomized trial
The Pharmacogenomics Journal (2022)
-
Disordered eating in early childhood: DRD4 and DAT1 gene polymorphisms and quality of mother–child interaction
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity (2022)
-
Pharmacogenetic profile and the development of the dyskinesia induced by levodopa-therapy in Parkinson’s disease patients: a population-based cohort study
Molecular Biology Reports (2020)
-
Association analyses reveal gender-specific associations of DAT1 40-bp VNTR and -839C/T polymorphisms with obsessive–compulsive disorder and obsessive–compulsive symptoms
Molecular Biology Reports (2019)